Browse studies
Find your next paid study
14 recruiting studies matching your filters
Phase 1
A Phase 1b, Open-label, Multicenter, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of AG-181 in Subjects With Phenylketonuria
The primary purpose of this study is to assess the safety and tolerability of AG-181 in subjects with Phenylketonuria (PKU).
Phenylketonuria
Agios Pharmaceuticals, Inc.NCT07241234
A Multi-Center, Observational Study to Evaluate the Long-Term Safety of Subcutaneous Injections of Palynziq® (Pegvaliase) in Subjects With Phenylketonuria
This is a 10-year multi-center, global, observational study to further characterize the safety profile of pegvaliase, including hypersensitivity reactions, lon…
Phenylketonuria (PKU)
BioMarin PharmaceuticalNCT05813678